Keloid Treatment Market

Future Market Insights suggests that within the keloid treatment landscape, the convergence of next-generation fractional laser platforms and emerging molecular inhibitor therapies is shifting the treatment paradigm from palliative scar management to targeted fibrotic pathway intervention. Analysts identify the regulatory clearance of advanced laser systems for keloid-specific pigmentation reduction and the clinical advancement of topical LOX inhibitors as the central pivot points for the industry, effectively expanding the addressable market from surgical excision and steroid injection to a multi-modal therapeutic approach.